U.S. Hotel and Resort REITs Stock News

On March 11, 2026, Oceaneering International Director M. Mcevoy sold 25,678 shares, while institutional investor Algert Global LLC lifted its stake to 649,747 shares. This mix of insider selling and increased institutional ownership highlights a contrast between board-level share reductions and growing professional investor interest in the company. We’ll now examine how Algert Global’s increased stake might influence Oceaneering International’s existing investment narrative and risk-return...

Intrepid Potash (IPI) has drawn fresh investor attention after reporting fourth quarter 2025 results that reduced its net loss to US$0.429 million and confirming plans to enter lithium production through the White Silver Lithium Project. See our latest analysis for Intrepid Potash. The share price has been building momentum, with a 30 day share price return of 26.71% and a 90 day share price return of 56.14%, while the 1 year total shareholder return sits at 45.02%. This reflects growing...

Earlier this month, MKS Inc.’s CEO highlighted at Morgan Stanley’s TMT Conference that the company now serves an estimated 85% of global semiconductor fabrication equipment and 70% of electronics and packaging processes, while also advancing new capacity with a 500,000 square-foot Malaysia facility scheduled to open in mid-2026. Separately, MKS’s short-term greenhouse gas reduction targets received Science Based Targets initiative validation and a board member disclosed a US$72,705 insider...

Waste Management (NYSE:WM) has formally recognized outgoing CFO Devina Rankin for her leadership in integrating the Healthcare Solutions business following the Stericycle acquisition. The acknowledgment also highlights her role in supporting the management transition as the company moves to a new CFO. This recognition underscores the importance of the Stericycle deal and the new Healthcare Solutions segment in Waste Management's business mix. For investors watching NYSE:WM, this leadership...

On March 12, 2026, Axcelis Technologies announced that Senior Vice President of Investor Relations and Corporate Strategy David Ryzhik was appointed Interim Chief Financial Officer, replacing departing CFO James Coogan, who will remain until April 24, 2026 to support the handover. The move places a long‑tenured finance and investor relations specialist at the center of Axcelis’s financial leadership, potentially sharpening how the company aligns capital allocation, messaging, and corporate...

Westinghouse Air Brake Technologies recently reported a stronger-than-expected fourth-quarter 2025 performance and reaffirmed confident 2026 guidance, emphasizing double-digit adjusted EPS growth, record cash generation, and support from a multi-year backlog despite industry headwinds. Around the same time, Executive Vice President of Sales & Marketing Gina Trombley sold 4,013 shares, highlighting ongoing insider selling that contrasts with the company’s upbeat operational outlook. Next,...

Cytokinetics recently announced that four presentations on MYQORZO™ (aficamten) for symptomatic obstructive hypertrophic cardiomyopathy were delivered at the American College of Cardiology 2026 Annual Scientific Session, highlighting new analyses from the SEQUOIA-HCM, MAPLE-HCM, and FOREST-HCM trials. The data underscored that aficamten improved exercise capacity versus placebo and metoprolol, maintained efficacy across patients with and without hypertension, and showed reassuring safety...

To put DTE Energy in context, you need to decide whether the current share price reflects fair value, a potential opportunity, or a risk of overpaying. DTE Energy's share price closed at US$149.34, with total returns of 1.1% over 7 days, 3.0% over 30 days, 14.6% year to date, 14.0% over 1 year, 55.8% over 3 years and 60.5% over 5 years. This gives you a useful snapshot of how the stock has behaved over different time frames. Recent company specific news has focused on DTE Energy's role as a...

Zions Bancorporation, N.A. recently became the focus of a securities fraud investigation after disclosing apparent misrepresentations and contractual defaults on two commercial and industrial loans in its California Bank & Trust division, prompting full provisioning and significant charge‑offs. At the same time, Zions is hosting a fraud prevention conference and has taken a lead role arranging a US$490 million credit facility for Varex Imaging, underscoring its dual position as both a risk...

On March 10, 2026, Markel Insurance appointed Kristen Dardia as Head of Portfolio Analytics for the US and Bermuda, tasking her with leading advanced analytics, technical pricing, and portfolio management after nearly two decades in actuarial science, analytics, and business strategy. Her track record embedding analytics into underwriting and portfolio decisions could meaningfully influence how Markel Group refines risk selection and pricing across its specialty insurance operations. Next,...

CSX expanded its Select Site initiative by awarding its designation to 21 new rail served properties across 10 states. Owens Corning announced a large manufacturing investment at a CSX Silver Select Site in Alabama, tied to about 100 new skilled jobs. This development reflects fresh industrial interest in CSX served locations, beyond recent discussions focused on valuation, margin outlook, and service metrics for NasdaqGS:CSX. For investors tracking NasdaqGS:CSX, this move adds a fresh...

Insulet (PODD) is in focus after disclosing an internal tubing defect in certain Omnipod 5 Pod lots, prompting a voluntary Medical Device Correction and free replacements. Production and new patient starts are expected to continue. See our latest analysis for Insulet. The tubing defect news has landed against a weak recent share price backdrop, with the 90 day share price return at a 20.4% decline and the 1 year total shareholder return at an 11.5% loss. This suggests that momentum has been...

In March 2026, Aldeyra Therapeutics reported that the FDA issued a Complete Response Letter for its reproxalap dry eye disease NDA, citing insufficient and inconsistent evidence of efficacy despite no safety or manufacturing concerns. An important nuance is that the FDA did not request new trials, instead urging Aldeyra to clarify why certain studies failed and where reproxalap might work best. We’ll now examine how the FDA’s efficacy concerns and lack of requested new trials reshape...

In early 2026, a joint SONAR and Ryder System report showed tender rejection rates climbing to nearly 14.3% in early February, reaching levels last seen during the pandemic and pointing to tightening trucking capacity. This spike in rejection rates hints at a shifting freight balance that could influence pricing power and operational conditions for logistics providers like Ryder. We’ll now examine how this jump in tender rejection rates could influence Ryder’s existing investment narrative...

Impinj recently entered privately negotiated agreements to repurchase approximately US$40.2 million of its 1.125% convertible notes due 2027 for cash, leaving about US$57.3 million outstanding after the March 16, 2026 closing. This sizable debt repurchase alters Impinj’s capital structure and could influence how investors assess its balance sheet strength and financial flexibility. Next, we’ll examine how Impinj’s sizable convertible note repurchase affects its existing investment narrative...

If you are wondering whether Rhythm Pharmaceuticals at around US$87.68 is still reasonably priced after its run, you are not alone. This article takes a closer look at what that level might mean for value focused investors. The stock has seen a 5.7% decline over the past week and a 10.6% decline over the last month, even after a 67.7% return over the past year and a very large gain over three years of about 4x. Recent coverage has highlighted investor interest following these sizeable multi...

Renasant (RNST) has drawn fresh attention after its recent share performance, with the stock down about 13% over the past month and 5% over the past 3 months, despite positive 1 year total returns. See our latest analysis for Renasant. The recent 13.4% 1 month share price decline, on top of a 5.4% 3 month share price fall, contrasts with Renasant's 4.6% 1 year total shareholder return. This suggests near term momentum is fading even as longer term investors remain modestly ahead. If you are...

Earnings event puts Buckle in focus Buckle (BKE) is back on investors’ radar after reporting Q4 and full year 2026 results, with higher sales and net income across both periods compared with the previous year. The fresh numbers give you an updated snapshot of how this apparel retailer is converting its store base and online presence into revenue and earnings, which can be useful context if you already hold the stock or track the retail sector. See our latest analysis for Buckle. The recent Q4...

If you are wondering whether Talos Energy at around US$13.96 is still offering value or if you might be late to the story, this breakdown will help you put the current share price into context. The stock has seen a 7.9% return over the last 7 days, 6.4% over the last 30 days, 24.1% year to date, and 56.9% over the past year, which can influence how investors think about both upside and risk. Recent coverage around Talos Energy has focused on its position in the US energy sector and how the...

Johnson Controls International (NYSE:JCI) has agreed to sell its residential HVAC business to Bosch, reallocating focus toward data center and service solutions. The company is expanding offerings for AI oriented data centers, including a partnership with NVIDIA to support advanced cooling needs. Management has highlighted backlog growth as evidence of strong demand for these focus areas. For investors tracking NYSE:JCI, this shift comes with the stock at $132.56 and a 1 year return of...

Rising oil and diesel prices are increasing operating costs for gold miners, including Agnico Eagle Mines. NYSE:AEM has hedged a meaningful portion of its diesel exposure, helping protect its cost structure and profit margins. This hedging approach is setting Agnico Eagle apart from peers facing similar inflation pressures without the same level of protection. Agnico Eagle Mines, NYSE:AEM, is drawing attention as higher fuel costs ripple through the gold mining sector. With shares at...

Traeger, Inc. has already implemented a 1-for-50 reverse stock split on March 18, 2026, following stockholder approval earlier in the month to address a New York Stock Exchange notice that its shares had traded below US$1.00 for 30 consecutive trading days. This reverse split, combined with recent weak 2025 results and ongoing losses, highlights how Traeger is using financial tools rather than operational improvements alone to preserve its exchange listing. Next, we'll explore how Traeger's...

Earlier in March 2026, Dauch Corporation announced it would present at the Bank of America Global Automotive Summit on March 17, and SEC filings revealed Director David Walker bought 35,000 company shares, bringing his total holdings to 35,000 shares. This combination of a high-profile investor conference appearance and fresh insider buying drew attention to how leadership is positioned alongside shareholders. Next, we’ll examine how Director David Walker’s insider share purchase may...

In March 2026, Zenas BioPharma reported a wider quarterly and full-year net loss alongside higher revenue, while also securing up to US$250,000,000 in non-dilutive term loan financing and filing a US$78,589,885 shelf registration linked to an ESOP-related common stock offering. This combination of a larger loss, incremental revenue from partnerships, and substantial new funding reshapes how the company can support obexelimab’s commercialization plans and broader pipeline activities. With...